To Evaluate the Safety, Efficacy,and Pharmacokinetics of Orally Administered Prolectin-M
Trial details
- Registry ID
- NCT05733780
- Drugs studied
- Prolectin-M
TrialRedline tracks 1 clinical trial sponsored by Bioxytran Inc.: 1 Phase 2.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| To Evaluate the Safety, Efficacy,and Pharmacokinetics of Orally Administered Prolectin-MNCT05733780 | Prolectin-M | Unknown | 2023-12Estimated |
Names as written in the registry records.